Trial Search Results

Study of Efficacy and Safety of CTL019 in Pediatric ALL Patients

The purpose of this study is to test the efficacy of modified T-cells in pediatric patients who have already been diagnosed with relapsed and refractory B-cell acute lymphoblastic leukemia.

Stanford is currently not accepting patients for this trial.

Stanford Investigator(s):

Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
CCTO
650-498-7061
Not Recruiting